Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 20Breast Neoplasms 10Fallopian Tube Neoplasms 9Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Lung Neoplasms 3Colonic Neoplasms 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Melanoma 2Hereditary Breast and Ovarian Cancer Syndrome 2Testicular Neoplasms 1Stage IV Fallopian Tube Cancer AJCC v6 and v7 1Renal Insufficiency 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Neoplasms, Unknown Primary 1Liver Failure 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Hepatocellular 1Brenner Tumor 1Breast Neoplasms, Male 1

Interventions

Paclitaxel 24Carboplatin 21Taxes 15Bevacizumab 9Cisplatin 7Immunoglobulin G 6Disulfides 6Topotecan 3Docetaxel 3paclitaxel poliglumex 2VTX-2337 2SS1(dsFv)PE38 2Platinum 2Peripheral Blood Stem Cell Transplantation 2Gemcitabine 2Filgrastim 2Etoposide 2Erlotinib Hydrochloride 2Chemotherapy, Adjuvant 21,2-diaminocyclohexaneplatinum II citrate 2veliparib 1trioctyl phosphine oxide 1sargramostim 1pegfilgrastim 1liposomal doxorubicin 1emactuzumab 1elesclomol 1dexamethasone acetate 1dexamethasone 21-phosphate 1belinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brenner Tumor × veliparib × Gynecologic × Clear all
NCT00989651 2021-10-20

Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 1 Completed
431 enrolled
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡